U
AMPE

UBS’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

UBS’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$22K Buy
21
+4
+24% +$6.74K ﹤0.01% 7916
2014
Q2 		$42K Buy
17
+10
+143% +$20.4K ﹤0.01% 7111
2014
Q1 		$13K Sell
7
-8
-53% -$18.9K ﹤0.01% 8627
2013
Q4 		$32K Buy
15
+7
+88% +$16.5K ﹤0.01% 7567
2013
Q3 		$18K Buy
+8
New +$15.5K ﹤0.01% 8212

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

UBS's AMPE Position: Q1 2014 in Review

UBS sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2014, closing a stake of 2 shares — an estimated $4.73K sold.

UBS first reported a position in AMPE in Q4 2013 and held it in 1 quarter. The position peaked at $4K in Q4 2013. 78 funds tracked by Wall St. Rank hold AMPE as of Q1 2014.

  • UBS reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2014 after selling out during the quarter.
  • UBS sold 2 Ampio Pharmaceuticals Inc. shares in Q1 2014, an estimated $4.73K.
  • UBS first reported a position in Ampio Pharmaceuticals Inc. in Q4 2013 and held it in 1 quarter.
  • UBS's Ampio Pharmaceuticals Inc. position peaked at $4K in Q4 2013.
  • 78 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2014.

Based on UBS's 13F filing for Q1 2014, filed 15 May 2014.